KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Emergent BioSolutions (EBS) over the last 15 years, with Sep 2025 value amounting to $0.91.

  • Emergent BioSolutions' EPS (Weighted Average and Diluted) fell 55.83% to $0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.31, marking a year-over-year increase of 132.51%. This contributed to the annual value of -$3.60 for FY2024, which is 75.76% up from last year.
  • Latest data reveals that Emergent BioSolutions reported EPS (Weighted Average and Diluted) of $0.91 as of Q3 2025, which was up 513.64% from -$0.22 recorded in Q2 2025.
  • Emergent BioSolutions' EPS (Weighted Average and Diluted)'s 5-year high stood at $3.60 during Q4 2021, with a 5-year trough of -$5.38 in Q2 2024.
  • Over the past 3 years, Emergent BioSolutions' median EPS (Weighted Average and Diluted) value was -$0.57 (recorded in 2024), while the average stood at -$1.52.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 612.50% in 2021, then crashed by 10,500.00% in 2022.
  • Over the past 5 years, Emergent BioSolutions' EPS (Weighted Average and Diluted) (Quarterly) stood at $3.60 in 2021, then crashed by 137.22% to -$1.34 in 2022, then spiked by 34.33% to -$0.88 in 2023, then soared by 35.23% to -$0.57 in 2024, then crashed by 55.83% to $0.91 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.91 in Q3 2025, compared to -$0.22 in Q2 2025 and $1.19 in Q1 2025.